北米のデジタルパソロジー市場2021-2028:製品別(ソフトウェア、デバイス)、用途別、最終用途別(癌専門病院、診断研究所)、地域別

◆英語タイトル:North America Digital Pathology Market Size, Share & Trends Analysis Report By Product (Software, Device), By Application, By End Use (Cancer Hospitals, Diagnostic Labs), By Region, And Segment Forecasts, 2021 - 2028
◆商品コード:GV21MC099
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2021年1月25日
◆ページ数:160
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:北米
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥678,300見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥792,300見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,020,300見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

グランドビューリサーチ社は、北米のデジタルパソロジー市場規模が2028年までに593.9百万ドルに達すると予測しています。2021年から2028年までに年平均6.5%成長する見通しです。本調査レポートでは、デジタルパソロジーの北米市場について調査・分析し、調査手法・範囲、エグゼクティブサマリー、製品別分析、用途別分析、最終用途別分析、市場変動・動向・範囲、潜在顧客分析、競争状況、企業情報などを掲載しています。
【レポートの概要】

North America Digital Pathology Market Growth & Trends
The North America digital pathology market size is expected to reach USD 593.9 million by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.5% from 2021 to 2028. The market is predominantly driven by the growing prevalence of chronic diseases such as cancer. As a consequence of the high prevalence of cancer, pathologists require data that facilitate personalizing therapy for patients. Hence, digital pathology is progressively being selected by pathologists as it has various benefits including accelerated diagnosis rate, diagnostic accuracy, and offers therapeutic recommendations to improve patient outcomes.

The growing number of collaborative agreements to develop as well as expedite the adoption of digital pathology in cancer diagnostics serves as a key growth factor contributing to the market. The use of artificial intelligence in digital pathology has gained momentum in the past years. The increasing need for lowering healthcare costs, increasing importance of big data in healthcare, rising adoption of precision medicine, and declining hardware costs are some factors driving the growth. In addition, increasing usage of artificial intelligence-based analytical tools in healthcare and high capital investments in this field are further propelling the market growth.

During the coronavirus outbreak, the exponential need for home-based workstations and safe clinical informatics systems allowing healthcare professionals to read images remotely and enabling virtual collaboration between their multi-disciplinary care teams has increased. Various histopathology departments in the region faced a reducing workforce and increasing workload during the pandemic. Digital pathology considered being the potential solution for some of the challenges faced by the pathologist, there is an increase in the adoption of digital diagnosis of disease during coronavirus outbreak.

In April 2020, Philips announced that the FDA granted a waiver for home use of consumer monitors with the company’s IntelliSite Pathology Solution during the emergency. The temporary exemption of restrictions on remote use of the digital pathology helps pathologists to access whole slide images from home and fasten the diagnosis of histology cases. Some pathology labs that have adopted DP in their workflows across different sites pre-COVID-19, reported improved collaboration, and an average productivity gain of 21.0% with operation efficiency increased by 13.0%. These types of initiatives are anticipated to fuel market growth.

North America Digital Pathology Market Report Highlights

• The software segment is anticipated to witness a lucrative growth rate of 6.8% in the coming years. The segment is inclusive of pathology workflow management solution and LIMS software

• This software is simple to install and use, easy to obtain specific patient information, and efficiently and quickly sends reports digitally to pathologists and clinicians. Owing to these associated advantages the software segment is expected to witness lucrative growth over the forecast period

• The practice of sharing digital imagery across labs helps in accelerating drug discovery and development processes by enabling pathologists to effectively analyze records and communicate and collaborate on crucial result findings in tissue-based efficacy studies

• The disease diagnosis segment is projected to witness a significant CAGR of 7.0% in the coming years as the FDA approved the practice of sharing digital imagery across labs for primary diagnosis applications such as cancer cell detection

• Diagnostic laboratories are expected to witness lucrative growth of 7.1% over the forecast period owing to the rising incidence of cancer in this region. Moreover, the implementation of digital pathology solutions and devices is likely to help improve laboratory workflow efficiency, accuracy, and quality of disease diagnosis using computational pathology

• Competitive rivalry in the market is expected to remain high over the forecast period. The market is dominated by few players such as Philips and Leica Biosystems that hold a majority of the revenue

• The strategies implemented by these players are product differentiation, new product launch, collaboration, merger, and acquisition to gain a larger share of the market

【レポートの目次】

Table of Contents

Chapter 1 Research Methodology & Scope
1.1 Market Segmentation & Scope
1.1.1 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database:
1.3.2 GVR’s Internal Database
1.3.3 Secondary sources
1.3.4 Primary Research:
1.3.5 Details of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Workflow Analysis (Model 1)
1.7 List of Primary Sources
1.8 List of Secondary Sources
1.9 List of Abbreviations
1.10 Market Definitions
1.11 Report Objectives
Chapter 2 Executive Summary
2.1 Market Outlook
2.1.1 North America North America Digital Pathology Market Outlook, 2016-2027 (USD Million)
2.2 North America North America Digital Pathology Market Summary, 2020
2.3 Segment Outlook
2.4 Regional Insights
2.4.1 U.S.
2.4.1.1 U.S. Digital Pathology market estimates and forecasts, 2016 – 2028 (USD Million)
2.4.2 Canada
2.4.2.1 Canada Digital Pathology market estimates and forecasts, 2016 – 2028 (USD Million)
2.5 Competitive Insights
Chapter 3 North America Digital Pathology Market: Product Estimates & Trend Analysis
3.1 North America Digital Pathology Market: Product Movement Analysis
3.2 Software
3.2.1 Software market estimates and forecasts, 2016 – 2028 (USD Million)
3.3 Devices
3.3.1 Device market estimates and forecasts, 2016 – 2028 (USD Million)
Chapter 4 North America Digital Pathology Market: Application Estimates & Trend Analysis
4.1 North America Digital Pathology Market: Application Movement Analysis
4.2 Drug Discovery & Development
4.2.1 Drug Discovery & Development market estimates and forecasts, 2016 – 2028 (USD Million)
4.3 Academic Research
4.3.1 Academic Research market estimates and forecasts, 2016 – 2028 (USD Million)
4.4 Disease Diagnosis
4.4.1 Disease Diagnosis market estimates and forecasts, 2016 – 2028 (USD Million)
4.4.2 Cancer cell Detection
4.4.2.1 Cancer cell detection market estimates and forecasts, 2016 – 2028 (USD Million)
4.4.3 Other applications
4.4.3.1 Other applications market estimates and forecasts, 2016 – 2028 (USD Million)
Chapter 5 North America Digital Pathology Market: End-use Estimates & Trend Analysis
5.1 North America Digital Pathology Market: End-use Movement Analysis
5.2 Cancer Hospitals
5.2.1 Hospitals market estimates and forecasts, 2016 – 2028 (USD Million)
5.3 Diagnostic Laboratories
5.3.1 Diagnostic Laboratories MARKET estimates and forecasts, 2016 – 2028 (USD Million)
5.3.2 Independent Pathology Labs
5.3.2.1 Independent Pathology labs market estimates and forecats, 2016 – 2028 (USD Million)
5.3.3 Large Pathology Labs
5.3.3.1 Large Pathology labs market estimates and forecats, 2016 – 2028 (USD Million)
5.4 Academic and Research Institutes
5.4.1 Academic and Research Institutes market estimates and forecasts, 2016 – 2028 (USD Million)
Chapter 6 North America Digital Pathology Market Variables, Trends & Scope
6.1 Market Lineage Outlook
6.1.1 Parent market outlook
6.1.2 Ancillary market outlook
6.2 Penetration & Growth Prospect Mapping
6.3 North America Digital Pathology Market Dynamics
6.3.1 Market Driver Analysis
6.3.1.1 Increasing prevalence of chronic diseases
6.3.1.2 Higher Cost-Efficiency
6.3.1.3 Rapid technological advancement
6.3.2 Market restraint analysis
6.3.2.1 Lack of reimbursement for digital pathology-enabled services
6.3.3 Industry Challenges
6.4 North America Digital Pathology Market Analysis Tools: Porters
6.5 SWOT Analysis By Factors (Political & Legal, Economic, Social and Technology)
6.6 Regulatory Framework
6.6.1 List of regulations
6.7 Political Landscape, Current & Future Scenario
6.7.1 List of regulations
6.8 Cost Structure Analysis
6.8.1 Price Erosion Analysis
Chapter 7 Potential Buyer Analysis
7.1 U.S. Demographic Information and Consumer Market Size
7.1.1 Pathology Laboratories
7.1.2 Hospitals
7.1.3 Academic & Research Institutes
7.2 List of Potential Customers
7.2.1 List of hospitals in the U.S
7.2.2 List of Pathology Laboratoreis in the U.S
7.2.3 Penetration of Digital Pathology
7.2.4 Estimated Penetration of Digital Pathology In Primary Read Vs Secondary in the U.S.
7.2.4.1 Estimated penetration of digital pathology in pathology laboratories
7.2.4.2 Estimated penetration of digital pathology in Cancer Hospitals
7.3 Future Outlook
7.3.1 User Perspective Analysis
7.3.1.1 Consumer behaviour analysis
7.3.1.2 Market influencer analysis
7.3.1.2.1 Consumer preference
7.3.1.2.2 Technology trends
7.3.1.2.3 Cost of implementation
7.3.2 Opportunity Analysis
7.3.2.1 Potential growth for digital pathology solutions
7.3.2.2 Market Entry Strategies
7.3.2.3 Regulatory requirements for new players
7.3.2.4 Competitive Strategies
7.4 Covid-19 Impact Analysis
7.4.1 COVID-19 Outbreak
7.4.2 Current Scenario
7.4.3 Demand Analysis
Chapter 8 North America Digital Pathology Market Competitive & Vendor Landscape
8.1 Participation Categorization
8.2 Public Companies
8.2.1 Estimated Company Market Share Analysis, 2020
8.2.2 Company market position analysis
8.3 Private Companies
8.3.1 Company market position analysis
8.3.2 Regional network map
8.3.3 List of emerging companies
8.4 Recent Developments & Impact Analysis, By Key Market Participants
8.4.1 Strategic Initiatives & Outcome Analysis
8.5 Major Deals And Strategic Alliances Analysis
8.6 Case Study
8.7 Detailed List of Players
8.7.1 List Of Distributors
8.7.2 List Of Key Companies, by Region
Chapter 9 Company Profiles
9.1 Danaher
9.1.1 Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.2 Hamamatsu Photonics, Inc.
9.2.1 Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic Initiatives
9.3 Koninklijke Philips N.V.
9.3.1 Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic Initiatives
9.4 Olympus Corporation
9.4.1 Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic Initiatives
9.5 F. Hoffmann-La Roche Ltd
9.5.1 Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic Initiatives
9.6 Mikroscan Technologies, Inc.
9.6.1 Company overview
9.6.2 FINANCIAL PERFORMANCE
9.6.3 Product benchmarking
9.6.4 Strategic Initiatives
9.7 3DHISTECH LTD
9.7.1 Company overview
9.7.2 FINANCIAL PERFORMANCE
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.8 Inspirata, Inc.
9.8.1 Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.9 Visiopharm A/S
9.9.1 Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.10 Huron Technologies International, Inc.
9.10.1 Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
Chapter 10 Key Opinion Leader (KOL) Commentary

List of Tables

Table 1 List of Abbreviations
Table 2 Cost breakdown: digital pathology
Table 3 List of hospitals in the U.S.
Table 4 List of pathology labs in the U.S.
Table 5 Digital Pathology Guidelines in North America
Table 6 Some of the strategic collaboration related to AI in medical imaging
Table 7 List of emerging companies
Table 8 List of distributors
Table 9 List of Key Companies, by Region


List of Figures

Fig. 1 Market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Commodity workflow analysis
Fig. 10 North America Digital Pathology Market revenue, 2016 - 2027 (USD Million)
Fig. 11 North America Digital Pathology Market snapshot
Fig. 12 North America Digital pathology Country outlook
Fig. 13 U.S. Digital Pathology market, 2016 - 2028 (USD Million)
Fig. 14 Canada Digital Pathology market, 2016 - 2028 (USD Million)
Fig. 15 Competitive insights
Fig. 16 North America Digital Pathology Market Product outlook: Key takeaways
Fig. 17 North America Digital Pathology Market: Product movement analysis
Fig. 18 Software market, 2016 - 2028 (USD Million)
Fig. 19 Device market, 2016 - 2028 (USD Million)
Fig. 20 North America Digital Pathology Market Application Outlook: Key takeaways
Fig. 21 North America Digital Pathology Market: Application Movement Analysis
Fig. 22 Drug discovery & development market, 2016 - 2028 (USD Million)
Fig. 23 Academic research market, 2016 - 2028 (USD Million)
Fig. 24 Disease diagnosis market, 2016 - 2028 (USD Million)
Fig. 25 Cancer cell detection market, 2016 - 2028 (USD Million)
Fig. 26 Other applications market, 2016 - 2028 (USD Million)
Fig. 27 North America Digital Pathology Market End-use outlook: Key takeaways
Fig. 28 North America Digital Pathology Market: End-use movement analysis
Fig. 29 Cancer hospitals market, 2016 - 2028 (USD Million)
Fig. 30 Diagnostic laboratories market, 2016 - 2028 (USD Million)
Fig. 31 Independent pathology laboratories market, 2016 - 2028 (USD Million)
Fig. 32 Large pathology laboratories market, 2016 - 2028 (USD Million)
Fig. 33 Academic and research institutes market, 2016 - 2028 (USD Million)
Fig. 34 Parent market outlook
Fig. 35 Ancillary Market Outlook
Fig. 36 Penetration & growth prospect mapping
Fig. 37 North America Digital Pathology Market dynamics
Fig. 38 North America Digital Pathology Market driver impact
Fig. 39 North America Digital Pathology Market restraint impact
Fig. 40 North America Digital Pathology Market: Porter’s five forces analysis
Fig. 41 SWOT Analysis, By Factor (Political & legal, economic and technological)
Fig. 42 U.S. Total Number of Pathology Laboratories, 2016 - 2025 ( Units )
Fig. 43 U.S. Total Number of Pathology Laboratories by Size of Laboratories, 2020 (% )
Fig. 44 U.S. Total Number of Hospitals, 2016 - 2025 (Units )
Fig. 45 U.S. Total Number of Hospitals by Specialty, 2020 (% )
Fig. 46 U.S. Total Number of Academic & Research Institutes, 2016 - 2025 ( Units )
Fig. 47 Digital Pathology Consumer Survey
Fig. 48 U.S. Digital Pathology: Primary vs secondary diagnosis, 2020 (%)
Fig. 49 U.S. Digital Pathology Penetration in pathology labs rate as of 2020 (%)
Fig. 50 U.S. Digital Pathology Penetration rate in cancer hospitals as of 2020 (%)
Fig. 51 Parameters considered by buyers for selecting digital pathology solutions
Fig. 52 Consumer behaviour analysis
Fig. 53 Market influencer analysis
Fig. 54 Recent developments & impact analysis, by key market participants in AI in medical imaging
Fig. 55 Market Participant Categorization
Fig. 56 Company Market Share Analysis, 2020
Fig. 57 Company market position analysis
Fig. 58 Company market position analysis
Fig. 59 Regional network map
Fig. 60 Key Companies and strategies
Fig. 61 Strategy mapping
Fig. 62 Digital Pathology: Case Study

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[北米のデジタルパソロジー市場2021-2028:製品別(ソフトウェア、デバイス)、用途別、最終用途別(癌専門病院、診断研究所)、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆